1 Relevant Concepts of Bevacizumab 1.1 Indications for Bevacizumab 1.2 Development of Bevacizumab in China 1.3 Governmental Approval of Bevacizumab in China 1.4 The Impact of COVID-19 on Bevacizumab sales in China 2 Sales of Bevacizumab in China, 2016-2020 2.1 Sales Value of Bevacizumab 2.1.1 Overall Sales Value 2.1.2 Sales Value by Region 2.2 Sales Volume of Bevacizumab 2.2.1 Overall Sales Volume 2.2.2 Sales Volume by Region 2.3 Sales of Bevacizumab by Dosage Form in China, 2016-2020 2.3.1 Injection 2.3.2 Analysis of Other Dosage Forms 3 Analysis of Major Bevacizumab Manufacturers in China, 2016-2020 3.1 Analysis of Market Share of Major Bevacizumab Manufacturers 3.1.1 Investigation on Market Share by Sales Value 3.1.2 Investigation on Market Share by Sales volume 3.2 Roche Pharma (Schweiz) AG 3.2.1 Enterprise Profile 3.2.2 Sales of AVASTIN (Roche's Bevacizumab) in China 3.3 Qilu Pharmaceutical Co., Ltd. 3.3.1 Enterprise Profile 3.3.2 Sales of Ankeda (Qilu's Bevacizumab) in China 3.4 Innovent Biologics (Suzhou) Co., Ltd. 3.4.1 Enterprise Profile 3.4.2 Sales of BYVASDA (Innovent's Bevacizumab) in China 4 Prices of Bevacizumab for Different Manufacturers in China, 2020-2021 4.1 Roche Pharma (Schweiz) AG (AVASTIN) 4.2 Qilu Pharmaceutical Co., Ltd. (Ankeda) 4.3 Innovent Biologics (Suzhou) Co., Ltd. (BYVASDA) 5 Prospect of Chinese Bevacizumab drug Market, 2021-2025 5.1 Influential Factors of Chinese Bevacizumab Market Development 5.1.1 The Impact of COVID-19 on Chinese Bevacizumab Market 5.1.2 Market Drivers and Opportunities 5.1.3 Market Threats and Challenges 5.2 Forecast on Market Size 5.3 Forecast on Market Trend List of Charts Chart Patent Information About Bevacizumab Injection Registration in China Chart Sales Value of Bevacizumab Injection over the World Chart Sales Value of Bevacizumab Injection in China, 2016-2020 Chart Sales Value of Bevacizumab Injection in China by Regions, 2016-2020 Chart Sales Volume of Bevacizumab Injection in China, 2016-2020 Chart Sales Volume of Bevacizumab Injection in China by Regions, 2016-2020 Chart Market Share by Sales Value of Top Bevacizumab Manufacturers in China, 2016-2020 Chart Sales Value and Volume of AVASTIN in China, 2016-2020 Chart Sales Value and Volume of Ankeda in China, 2016-2020 Chart Sales Value and Volume of BYVASDA in China, 2016-2020 Chart Referential Prices of AVASTIN in China, 2020-2021 Chart Referential Prices of Ankeda in China, 2020-2021 Chart Referential Prices of BYVASDA in China, 2020-2021 Chart Forecast on Sales Value of Bevacizumab in China, 2021-2025 Chart Forecast on Sales Volume of Bevacizumab in China, 2021-2025